EUVIMEDEUVIMED entdecken
Crossref

Spatial Metabolic Covariance Networks in Progressive Supranuclear Palsy: Implications for Symptomatology and Their Neural Basis

Bo Wang iD, Haotian Wang iD, Yixin Kang, Sheng Wu, Nan Jin, Haoyu Wang, Zhidong Cen iD, Dehao Yang, Xinhui Chen iD, Xiaofeng Dou, Congcong Yu, Yan Zhong und 3 weitere

Movement Disorders · 2025

DOI: 10.1002/mds.70099 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders, 2025. Verfasst von Bo Wang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Supranuclear Palsy, Progressive, Brain, Nerve Net. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Program of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Progressive supranuclear palsy (PSP) is a clinically heterogeneous neurodegenerative disorder with unclear pathophysiology.

Objective

This study aimed to uncover clinically relevant metabolic networks derived from 18 F‐fluorodeoxyglucose (FDG) positron emission tomography (PET) in PSP.

Methods

FDG and dopaminergic transporter PET data from 72 PSP patients and 70 healthy controls were analyzed, with an independent test set of 24 PSP patients. All patients underwent comprehensive neuropsychiatric assessments. Using spatial independent component analysis, the study identified independent metabolic networks and examined their correlations with clinical features and striatal dopaminergic binding.

Results

Three distinct metabolic networks were identified in PSP: The first network demonstrated hypometabolism in dorsomedial thalamus (dmT), medial prefrontal cortex (mPFC) and midbrain, termed the dmT‐mPFC network, negatively correlating with disease severity, functional disability and duration, and associating with gait/midline disturbances and ocular dysfunction. The second network displayed posterior cingulate cortex (PCC) and lateral prefrontal hypometabolism (LPFC), named the PCC‐LPFC network, linking to disease severity, cognitive impairment, and parkinsonism. The third network exhibited preserved putamen metabolism with ventrolateral thalamus and sensorimotor cortex hypermetabolism, inversely relating to disease duration. Both dmT‐mPFC and PCC‐LPFC networks strongly correlated with striatal dopaminergic degeneration. The test set showed strong associations between cognitive impairment and the PCC–LPFC network, and between functional disability and the dmT–mPFC network, along with potential trends linking disease severity to these networks.

Conclusion

The robust clinical and dopaminergic‐related independent metabolic networks offer novel insights into disease pathophysiology, whereas their qualitative weighting offers a potential tool for staging disease severity. © 2025 International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Supranuclear Palsy, ProgressiveBrainNerve NetHumansMaleFemaleAgedPositron-Emission TomographyMiddle AgedFluorodeoxyglucose F18Prefrontal CortexThalamus

Stichwörter der Autor:innen

covariance networkdopaminergic transporterfluorodeoxyglucoseprogressive supranuclear palsyspatial independent component analysis

Substanzen

Fluorodeoxyglucose F18

Autor:innen und Institutionen

  • Department of Neurology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Nuclear Medicine and PET-CT Center, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Human Phenome Institute, Fudan University, Shanghai, China.
  • Huashan Hospital, Fudan University, Shanghai, China.
  • Key Laboratory for Biomedical Engineering of Ministry of Education, Zhejiang University, Hangzhou, China.
  • The College of Biomedical Engineering and Instrument Science, Zhejiang University, Hangzhou, China.

ORCID-Profile: Bo Wang, Haotian Wang, Zhidong Cen, Xinhui Chen, Wei Luo

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Program of Zhejiang Province

Zitieren

APA

Wang, B., Wang, H., Kang, Y., Wu, S., Jin, N., Wang, H., Cen, Z., Yang, D., Chen, X., Dou, X., Yu, C., Zhong, Y., Tian, M., Zhang, H., & Luo, W. (2025). Spatial Metabolic Covariance Networks in Progressive Supranuclear Palsy: Implications for Symptomatology and Their Neural Basis. Movement Disorders. https://doi.org/10.1002/mds.70099

Vancouver

Wang B, Wang H, Kang Y, Wu S, Jin N, Wang H, et al. Spatial Metabolic Covariance Networks in Progressive Supranuclear Palsy: Implications for Symptomatology and Their Neural Basis. Movement Disorders. 2025. doi:10.1002/mds.70099

BibTeX
@article{Wang2025,
  author = {Wang, Bo and Wang, Haotian and Kang, Yixin and Wu, Sheng and Jin, Nan and Wang, Haoyu and Cen, Zhidong and Yang, Dehao and Chen, Xinhui and Dou, Xiaofeng and Yu, Congcong and Zhong, Yan and Tian, Mei and Zhang, Hong and Luo, Wei},
  title = {Spatial Metabolic Covariance Networks in Progressive Supranuclear Palsy: Implications for Symptomatology and Their Neural Basis},
  journal = {Movement Disorders},
  year = {2025},
  doi = {10.1002/mds.70099}
}
Kostenlos starten →